Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

InflaRx (IFRX) Shares Issued (2017 - 2025)

InflaRx's Shares Issued history spans 6 years, with the latest figure at $7.9 million for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.8 million, a N/A change, with the full-year FY2025 number at $26.7 million, up 2171.39% from a year prior.
  • Shares Issued hit $7.9 million in Q4 2025 for InflaRx, down from $17.0 million in the prior quarter.
  • Over the last five years, Shares Issued for IFRX hit a ceiling of $60.5 million in Q4 2023 and a floor of $123044.1 in Q2 2023.
  • Historically, Shares Issued has averaged $14.7 million across 3 years, with a median of $5.1 million in 2025.
  • The widest YoY moves for Shares Issued: up 2426.35% in 2023, down 2426.35% in 2023.
  • Tracing IFRX's Shares Issued over 3 years: stood at $2.4 million in 2022, then surged by 2426.35% to $60.5 million in 2023, then plummeted by 87.0% to $7.9 million in 2025.
  • Business Quant data shows Shares Issued for IFRX at $7.9 million in Q4 2025, $17.0 million in Q1 2025, and $60.5 million in Q4 2023.